New Key Statistics Module, Z-Score and F-Score
OTCPK:ETXPF Key Ratios
| Market Cap $ M | 75.96 |
| Enterprise Value $ M | 44.68 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 1.91 |
| Price/Sales | 90.00 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | -- |
| EPS (TTM) $ | -0.02 |
| Beneish M-Score | -2 |
| 10-y EBITDA Growth Rate % | 10.10 |
| 5-y EBITDA Growth Rate % | 4.90 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -2.35 |
| EV-to-EBITDA | -2.45 |
| PEG | -- |
| Shares Outstanding M | 584.34 |
| Net Margin (%) | -2,957.65 |
| Operating Margin % | -3,721.77 |
| Pre-tax Margin (%) | -3,494.71 |
| Quick Ratio | 22.20 |
| Current Ratio | 22.20 |
| ROA % (ttm) | -33.90 |
| ROE % (ttm) | -35.52 |
| ROIC % (ttm) | -394.21 |
| Dividend Yield % | -- |
| Altman Z-Score | 16.74 |
ETXPF Number of Guru Trades
ETXPF Volume of Guru Trades
Gurus Latest Trades with OTCPK:ETXPF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:ETXPF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
e-Therapeutics PLC Insider Transactions
No Available Data
News about OTCPK:ETXPF
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers